Consumer Health Cancer / Oncology
Ono Pharmaceutical Partners with Congruence Therapeutics to Advance Oncology Drug Discovery
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that it has entered into a drug discove...
December 09, 2024 | News
Gilead Sciences and Tubulis Forge Strategic Partnership to Advance Antibody-Drug Conjugates for Solid Tumors
Gilead Sciences, Inc. and Tubulis announced that they have entered into an exclusive option and license agreement to discover and develop a...
December 05, 2024 | News
Innovent and HUTCHMED Secure Conditional Approval in China for TYVYT® and ELUNATE® Combo in Advanced Endometrial Cancer
Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
December 04, 2024 | News
AstraZeneca's Drive to Transform Lung Cancer Care in LMICs
In an exclusive interview with BioPharma APAC, Ti Hwei How, Vice President of International Oncology & Market Access at AstraZeneca, sh...
December 02, 2024 | Interview
India Becomes Third Country to Launch Dr. Reddy’s Toripalimab, a Next-Gen Immuno-Oncology Therapy
Dr. Reddy’s Laboratories Ltd., in collaboration with Shanghai Junshi Biosciences Co. Ltd., today announced the launch of Toripalimab under the brand ...
November 29, 2024 | News
Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies
Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...
November 29, 2024 | News
Viz.ai Partners with Microsoft to Advance AI-Powered Disease Detection and Care Coordination in Healthcare
Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Microsoft to deliver its AI models...
November 28, 2024 | News
Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...
November 28, 2024 | News
Lunit Partners with Mexico's Salud Digna to Advance AI-Driven Cancer Diagnostics Across Latin America
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with&nbs...
November 28, 2024 | News
QIAGEN’s QIAcuityDx Digital PCR System Approved by ARTG to Enhance Clinical Diagnostics Across Australia and New Zealand
Provides absolute quantitation, essential for precise monitoring of low-abundance targets in clinical diagnostics Enhances lab effic...
November 26, 2024 | News
Akeso's Penpulimab and Anlotinib Combo Accepted by NMPA for First-Line Advanced Liver Cancer Treatment
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accep...
November 25, 2024 | News
Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets
Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...
November 21, 2024 | News
Mongolian Health Officials Tour SD Biosensor Facilities in Korea to Strengthen Infectious Disease Collaboration
A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factori...
November 21, 2024 | News
Lunit and AstraZeneca Collaborate in South Korea to Transform Lung Cancer Diagnostics with AI-Powered Genotype Predictor
Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations Lunit (KRX:3281...
November 19, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
